Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | ERN1 | O75460 | 4/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | STS | P08842 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8702460 | 0.84 | ALDH1A1 (0.57) | ALDH1A1ERN1CA1CA2TDP1 | |
| SCHEMBL21660344 | 0.84 | ALDH1A1 (0.59) | ALDH1A1ERN1CA1CA2MAPT | |
| SCHEMBL2558631 | 0.84 | PARP10 (0.59) | ALDH1A1ERN1CA1CA2LMNA | |
| SCHEMBL24515546 | 0.81 | ERN1 (0.54) | ALDH1A1ERN1CA1CA2TDP1 | |
| SCHEMBL4597626 | 0.81 | LMNA (0.53) | ALDH1A1ERN1CA1CA2TDP1 | |
| SCHEMBL69218 | 0.79 | CA1 (0.75) | ALDH1A1CA1CA2TDP1MAPT | |
| SCHEMBL9114889 | 0.78 | LMNA (0.50) | ALDH1A1ERN1TDP1MAPTLMNA | |
| SCHEMBL4598157 | 0.78 | ALDH1A1 (0.82) | ALDH1A1CA1CA2TDP1MAPT | |
| SCHEMBL4597491 | 0.77 | ALDH1A1 (0.53) | ALDH1A1ERN1CA1CA2TDP1 | |
| SCHEMBL20772350 | 0.77 | ALDH1A1 (0.58) | ALDH1A1CA1CA2TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | ANORMED, INC. (CA) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | CCR5, CCR4, CCR1 | ALDH1A1 3484/4885ERN1 2682/4885CA1 3985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.